JP2006519824A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519824A5
JP2006519824A5 JP2006505924A JP2006505924A JP2006519824A5 JP 2006519824 A5 JP2006519824 A5 JP 2006519824A5 JP 2006505924 A JP2006505924 A JP 2006505924A JP 2006505924 A JP2006505924 A JP 2006505924A JP 2006519824 A5 JP2006519824 A5 JP 2006519824A5
Authority
JP
Japan
Prior art keywords
compound
administered
disease
treatment
side effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2006505924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519824A (ja
Filing date
Publication date
Priority claimed from GBGB0305150.5A external-priority patent/GB0305150D0/en
Application filed filed Critical
Publication of JP2006519824A publication Critical patent/JP2006519824A/ja
Publication of JP2006519824A5 publication Critical patent/JP2006519824A5/ja
Ceased legal-status Critical Current

Links

JP2006505924A 2003-03-07 2004-03-05 アデノシン受容体アゴニストの治療上の使用 Ceased JP2006519824A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0305150.5A GB0305150D0 (en) 2003-03-07 2003-03-07 Use of therapeutic compounds
PCT/GB2004/000952 WO2004078184A1 (en) 2003-03-07 2004-03-05 Use of adenosine receptor agonists in therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012001451A Division JP2012111764A (ja) 2003-03-07 2012-01-06 アデノシン受容体アゴニストの治療上の使用

Publications (2)

Publication Number Publication Date
JP2006519824A JP2006519824A (ja) 2006-08-31
JP2006519824A5 true JP2006519824A5 (cg-RX-API-DMAC7.html) 2007-05-10

Family

ID=9954248

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006505924A Ceased JP2006519824A (ja) 2003-03-07 2004-03-05 アデノシン受容体アゴニストの治療上の使用
JP2012001451A Pending JP2012111764A (ja) 2003-03-07 2012-01-06 アデノシン受容体アゴニストの治療上の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012001451A Pending JP2012111764A (ja) 2003-03-07 2012-01-06 アデノシン受容体アゴニストの治療上の使用

Country Status (11)

Country Link
US (2) US7790698B2 (cg-RX-API-DMAC7.html)
EP (1) EP1603576A1 (cg-RX-API-DMAC7.html)
JP (2) JP2006519824A (cg-RX-API-DMAC7.html)
KR (1) KR20050115895A (cg-RX-API-DMAC7.html)
CN (2) CN1809365A (cg-RX-API-DMAC7.html)
AU (1) AU2004216891B2 (cg-RX-API-DMAC7.html)
CA (1) CA2514848A1 (cg-RX-API-DMAC7.html)
GB (1) GB0305150D0 (cg-RX-API-DMAC7.html)
NO (1) NO20054475L (cg-RX-API-DMAC7.html)
NZ (1) NZ541587A (cg-RX-API-DMAC7.html)
WO (1) WO2004078184A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0228723D0 (en) * 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305150D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds
GB0305153D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
KR20070004792A (ko) * 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
BRPI0517639A (pt) * 2004-11-08 2008-10-14 Can Fite Biopharma Ltd método para o tratamento de ressorção óssea acelerada, composição farmacêutica, e, uso de um agonista de a3ar
AU2006204699B2 (en) * 2005-01-13 2012-04-26 Sirtris Pharmaceuticals, Inc. Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
JP5339916B2 (ja) * 2005-11-30 2013-11-13 キャン−ファイト・バイオファーマ・リミテッド 骨関節炎の治療におけるa3アデノシン受容体アゴニストの使用
NZ573308A (en) 2006-06-27 2012-02-24 Biovitrum Ab Publ Adenosine derivatives for the treatment of pain
CN101479268B (zh) 2006-06-27 2012-08-08 Cbt发展有限公司 2-0’-甲基腺苷衍生物及其用作制备腺苷受体的激动剂或拮抗剂的应用
US7906518B2 (en) 2006-06-27 2011-03-15 Cbt Development Limited Therapeutic compounds
EP2451456A1 (en) * 2009-07-09 2012-05-16 CBT Development Limited Combined preparation for use as a medicament
CN101947230B (zh) * 2010-08-25 2012-10-10 苗志敏 5’-amp用于治疗痛风性关节炎的用途
CN103342727A (zh) * 2013-07-01 2013-10-09 淮海工学院 一种2-甲氧基腺苷的合成方法
CN108329372B (zh) * 2017-01-20 2022-07-26 浙江省亚热带作物研究所 N6-(2-羟乙基)腺苷及其衍生物在制备治疗痛风药物中的应用
JP7025129B2 (ja) * 2017-05-17 2022-02-24 小林製薬株式会社 筋痙攣治療剤
WO2020176544A1 (en) * 2019-02-25 2020-09-03 Saint Louis University Treatment of alzheimer's disease
JPWO2022050230A1 (cg-RX-API-DMAC7.html) * 2020-09-03 2022-03-10
CN113116900B (zh) * 2021-04-14 2022-07-08 兰州大学 一类核苷类似物在制备预防和/或治疗脑血管疾病药物中的应用
DE202025102658U1 (de) 2025-04-02 2026-08-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung Darreichungsform, insbesondere für die muskuläre Balance

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792155A (fr) 1971-12-01 1973-05-30 Takeda Chemical Industries Ltd Nouveaux derives de l'adenosine et leur procede de production
JPS4861498A (cg-RX-API-DMAC7.html) 1971-12-01 1973-08-28
DE2359536C2 (de) 1972-12-08 1984-08-02 Takeda Chemical Industries, Ltd., Osaka 2,6-Diaminonebularinderivate
JPS5461195A (en) 1977-10-21 1979-05-17 Takeda Chem Ind Ltd N2-substituted phenyl-2,6-diaminonebularin
JPS5461194A (en) 1977-10-21 1979-05-17 Takeda Chem Ind Ltd Preparation of n22substituted 2*66diaminonebularin
US4705758A (en) 1984-06-19 1987-11-10 Warner-Lambert Company Adenosine receptor assay and kit
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
US5231086A (en) * 1985-09-24 1993-07-27 Item Development Aktiebolag Continuous administration adenosine to increase myocardial blood flow
US6180616B1 (en) * 1990-05-10 2001-01-30 Atsuo F. Fukunaga Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
US5877180A (en) * 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
IT1275420B (it) 1995-06-02 1997-08-05 Schering Plough S P A Metodo per misurare l'affinita' di legame al recettore a2a dell'adenosina di componenti di interesse farmacologico mediante l'uso del ligando triziato (3h)-sch 58261
JP2002500188A (ja) * 1998-01-08 2002-01-08 ザ・ユニバーシティ・オブ・バージニア・パテント・ファウンデーション A2aアデノシンレセプター作動因子
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
GB0305153D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
GB0305150D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds

Similar Documents

Publication Publication Date Title
TW199861B (cg-RX-API-DMAC7.html)
AU2014277506B2 (en) Bisulfate of Janus kinase (JAK) inhibitor and preparation method therefor
JP2020537657A5 (cg-RX-API-DMAC7.html)
JP2024516371A5 (cg-RX-API-DMAC7.html)
JP2019519598A5 (cg-RX-API-DMAC7.html)
JP2005194283A5 (cg-RX-API-DMAC7.html)
JP2007526291A5 (cg-RX-API-DMAC7.html)
US10913766B2 (en) Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof
JP2007508336A5 (cg-RX-API-DMAC7.html)
JP2014510746A5 (cg-RX-API-DMAC7.html)
EP1460077A1 (en) Novel pyrazolopyrimidones and their use as PDE inhibitors
CN1387530A (zh) 用作磷酸二酯酶vii抑制剂的咪唑并吡啶衍生物
HUE032004T2 (en) Use of a pyrazole derivative for the treatment of acute severe conditions of chronic obstructive airways disease
JP2022527401A5 (cg-RX-API-DMAC7.html)
JP2006519823A5 (cg-RX-API-DMAC7.html)
US11883423B2 (en) Nucleobase analogue derivatives and their applications
JP2010518154A5 (cg-RX-API-DMAC7.html)
WO2016066555A1 (en) Crystalline forms of ferric maltol
JP2023538645A (ja) ボロン酸化合物
WO2018217139A4 (ru) Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний
JP2023502531A5 (cg-RX-API-DMAC7.html)
WO2009089702A1 (en) Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same
JP7522414B2 (ja) Jakキナーゼ阻害剤、その調製および適用
JP2011504890A5 (cg-RX-API-DMAC7.html)
EP0999840B1 (en) Use of a draflazine analogue for treating pain